Teva Invests in Yeast-based Drug Discovery Technology
By Sally Mardikian PhD
Pharma Deals Review: Vol 2008 Issue 103 (Table of Contents)
Published: 15 Dec-2008
DOI: 10.3833/pdr.v2008.i103.100 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Teva has entered into an agreement with Yissum, the Hebrew University of Jerusalem technology transfer company, to finance a yeast-based drug discovery technology developed by Jexys, a Yissum subsidiary...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018